Back

Genmab AS Quote, Financials, Valuation and Earnings

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.

Sell

GMAB
Genmab AS

Last Price:

20.47

Seasonality Move:

3.28%

7 Day Trial

ALL ACCESS PASS

$ 7

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Genmab AS Price Quote

$20.47

+0.02 (+0.1%)

(Updated: November 21, 2024 at 11:40 AM ET)

Genmab AS Key Stats

Sell

Genmab AS (GMAB) is a Sell

Day range:

$20.36 - $20.55

52-week range:

$20.50 - $32.88

Dividend yield:

P/E ratio:

21.56

P/S ratio:

4.66

P/B ratio:

2.75%

Volume:

1.1M

Avg. volume:

1.5M

1-year change:

-37%

Market cap:

$13.1B

Revenue:

$2.4B

EPS:

$1.05

How Much Does Genmab AS Make?

How Much Are Genmab AS's Sales Annually?
GMAB Revenues are $2.4B
How Much Profit Does Genmab AS's Make A Year?
GMAB net income is $631.9M

Is Genmab AS Growing As A Company?

What Is Genmab AS's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.19%
What Is Genmab AS's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is -0.37%

Genmab AS Stock Price Performance

Did Genmab AS Stock Go Up Last Month?
Genmab AS share price went down by -11.01% last month
Did GMAB's Share Price Rise Over The Last Year?
GMAB share price fell by -37% over the past 1 year

What Is Genmab AS 52-Week High & Low?

What Is Genmab AS’s 52-Week High Share Price?
Genmab AS has traded as high as $32.88 over the past 52 weeks
What Is Genmab AS’s 52-Week Low Share Price?
Genmab AS has traded as low as $20.50 over the past 52 weeks

Genmab AS Price To Free Cash Flow

Is Genmab AS Stock Overvalued?
Genmab AS is trading at a price to free cash flow ratio of 14.04
Is Genmab AS Stock Undervalued?
Genmab AS EV to Free Cash Flow ratio is 10.99
What Is Genmab AS’s Price Earnings Growth Ratio?
GMAB PEG ratio is 1.31
Is Genmab AS Trading At A Premium To Earnings?
Genmab AS EV to EBIT ratio is 10.99

Is It Risky To Buy Genmab AS?

How Much Debt Does Genmab AS Have?
Total long term debt quarterly is $0
How Much Cash Does Genmab AS Have?
Cash and short term investments quarterly total is $2.6B
What Is Genmab AS’s Book Value Per Share?
Book value per share is 7.53

Is Genmab AS Cash Flow Positive?

What Is GMAB Cash Flow From Operations?
Cash flow from operations (TTM) is $983.5M
What Is Genmab AS’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$580.7M
What Is Genmab AS’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$1.5B

Genmab AS Return On Invested Capital

Is Management Doing A Good Job?
GMAB return on invested capital is 14.86%
What Is Genmab AS Return On Assets?
ROA measures how assets are converting to revenues and is 12.66%
What Is GMAB Return On Equity?
ROE is a measure of profitability and is 14.86%

Genmab AS Earnings Date & Stock Price

What Is Genmab AS's Stock Price Today?
A single share of GMAB can be purchased today for 20.45
What Is Genmab AS’s Stock Symbol?
Genmab AS trades on the nasdaq under the ticker symbol: GMAB
When Is Genmab AS’s Next Earnings Date?
The next quarterly earnings date for Genmab AS is scheduled on May 8, 2025
When Is GMAB's next ex-dividend date?
Genmab AS's next ex-dividend date is November 21, 2024
How To Buy Genmab AS Stock?
You can buy Genmab AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Genmab AS Competitors

Who Are Genmab AS's Competitors?
Below is a list of companies who compete with Genmab AS or are related in some way:
- Ascendis Pharma AS (ASND)
- Evaxion Biotech AS (EVAX)
- Galecto Inc (GLTO)
- IO Biotech Inc (IOBT)
- Novo Nordisk AS (NVO)

Genmab AS Dividend Yield

What Is GMAB Dividend Yield?
Genmab AS’s dividend yield currently is 0%
What Is Genmab AS’s Payout Ratio?
Genmab AS’s payout ratio is 0%
When Did Genmab AS Last Pay A Dividend?
The latest dividend pay date is November 21, 2024
What Is Genmab AS’s Dividend Per Share?
Genmab AS pays a dividend of $0.00 per share

Genmab AS Analyst Estimates

	YoY Growth	Past Surprise
EPS:	-37.41%	-12.85%
Revenue:	18.65%	-0.87%

Analyst Recommendations

Buy Recommendations:	2
Hold Recommendations:	5
Sell Recommendations:	0
Price Target:	37.56
Upside from Last Price:	83.65%

Major Shareholders

How many GMAB shares are owned by institutional investors?
64.1M GMAB shares are owned by institutional investors
How many GMAB shares are owned by insiders?
0 GMAB shares are owned by insiders